Thanks to the advances in scientific research and development, many peptide-based therapies are in the pipeline, and in just a few short years the world can enjoy such therapies at affordable costs. A few years ago, there were less than fifty approved peptide-based medications in the market, but this number has since grown exponentially.

Today, there are over 400 drugs in various stages of the testing and approval cycle, and we can rightly say that commercial peptide synthesis technology will revolutionise the pharmaceutical industry.

Peptide-based medicines are very effective because they take advantage of the very biomolecules that run various aspects of human physiology. Therefore, they result in more substantive and effective reactions in the human body while simultaneously minimizing the side effects usually caused by introducing non-native substances into the human body.